Press release
The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:
A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.
A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.
Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).
An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.
A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.
An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.
An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.
An analysis to identify the key performance indicators for service providers active in the domain.
A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.
A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.
A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Types of Primary Packaging Containers
Ampoules
Cartridges
Syringes
Vials
Types of Biologics
Peptides / proteins
Antibodies
Vaccines
Cell therapies
Gene therapies
Viral products
Oligonucleotides
Others
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Company Size
Small-sized
Mid-sized
Large / very large
Scale of Operation
Preclinical
Clinical
Commercial
Key Therapeutic Areas
Cancer
Infectious diseases
Autoimmune diseases
Cardiovascular diseases
Other indications
Key Geographical Regions
North America (US, Canada)
Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
Asia-Pacific (Japan, China, South Korea, India and Australia)
The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:
Ales Sima, Business Development Manager, oncomed manufacturing
Gregor Kawaletz, Chief Commercial Officer, IDT Biologika
Jos Vergeest, International Business Developer, HALIX
Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International
Key companies covered in the report
Advanced BioScience Laboratories (ABL)
Albany Molecular Research (AMRI)
Biocon
BioPharma Solutions
BioReliance
Boehringer Ingelheim BioXcellence
ChemPartner
Emergent BioSolutions
IDT Biologika
Lonza
LuinaBio
Mycenax Biotech
Patheon
Recipharm
Vetter Pharma
WuXi Biologics
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Other Recent Offerings
1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030
2. Medical Device Contract Manufacturing Market, 2019-2030
3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures
4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
5. Patient Recruitment and Retention Services Market, 2019-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis here
News-ID: 2205168 • Views: …
More Releases from Roots Analysis
Autoinjectors Market to Reach USD 299 Billion by 2035 at 5.7% CAGR | SHL Medical …
The global autoinjectors market, valued at USD 170 billion in 2025, will reach USD 181 billion in 2026 and climb to USD 299 billion by 2035, advancing at a CAGR of 5.7% over the forecast period. The growth reflects accelerating demand for self-administration devices across chronic disease management, a wave of biosimilar launches entering autoinjector formats, and a measurable shift in patient care from clinical settings to home environments.
To access…
Antiviral Drugs Market to Reach USD 127 Billion by 2035, Growing at 6.1% CAGR | …
The global antiviral drugs market, valued at USD 69 billion in 2025, will reach USD 74 billion in 2026 and climb to USD 127 billion by 2035, advancing at a CAGR of 6.1% over the forecast period. Infectious disease burden, accelerating R&D pipelines, and the post-pandemic push for novel antivirals are collectively reshaping this market into one of the pharmaceutical sector's most active growth categories.
To explore the complete findings, request…
Antibody Drug Conjugate (ADC) Market to Reach $28.41 Billion by 2035 | AstraZene …
The global antibody drug conjugate (ADC) market, valued at USD 15.29 billion in 2025, will grow to USD 18.69 billion in 2026 and reach USD 28.41 billion by 2035, advancing at a CAGR of 4.8% through the forecast period. With 19 approved therapies already on the market and an active clinical pipeline spanning hundreds of programs, the ADC sector has moved well past proof-of-concept and into a sustained commercial expansion…
Antibody Discovery Services and Platforms Market to Reach $6.3 Billion by 2035 a …
The global antibody discovery market, valued at $2.0 billion in 2025, will climb to $2.2 billion in 2026 and reach $6.3 billion by 2035, compounding at a CAGR of 12.3% over the forecast period. Surging demand for targeted biologics, a record pace of monoclonal antibody approvals, and the accelerating adoption of AI-assisted discovery platforms are converging to make this one of the most commercially consequential segments in the life sciences…
More Releases for Biologics
Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top C …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad
DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by…
Platinum Biologics Highlights Rising Consumer Confusion in the Biologics Market
[Orlando, USA - March 27, 2026] - A growing wave of consumer uncertainty is reshaping how patients and buyers approach the biologics market, particularly in emerging categories such as exosomes. As interest accelerates, so does confusion-driven by inconsistent standards, complex terminology, and a flood of marketing claims that are difficult for non-experts to verify.
Recent observations shared by Platinum Biologics point to a clear behavioral shift: consumers are no longer relying…
Biologics CDMO Services Market is Booming Worldwide | Lonza Group, Catalent, Sam …
The latest study released on the Global Biologics CDMO Services Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Biologics CDMO Services study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Major…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market
What is the…
